Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGIO-ED: Angiotensin II for Septic Shock in the ED
NCT06693726Phase 4Recruiting
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in septic shock. Started Apr 2025; status: recruiting.
02
Drugs
Angiotensin II
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06693726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06693726.